Education
About Us
Working with TipRanks
Follow Us
Oncodesign Precision Medicine S.A. (FR:ALOPM)
:ALOPM
ALOPM Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.28 - €1.38
Previous CloseN/A
Volume28.87K
Average Volume (3M)18.98K
Market Cap
€7.17M
Enterprise Value€15.23M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)1.1
Beta-0.13
Next Earnings
Apr 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.54
Shares Outstanding18,190,878
10 Day Avg. Volume20,347
30 Day Avg. Volume18,975
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ALOPM FAQ
What was Oncodesign Precision Medicine S.A.’s price range in the past 12 months?
Oncodesign Precision Medicine S.A. lowest stock price was €0.28 and its highest was €1.38 in the past 12 months.
What is Oncodesign Precision Medicine S.A.’s market cap?
Oncodesign Precision Medicine S.A.’s market cap is €7.17M.
When is Oncodesign Precision Medicine S.A.’s upcoming earnings report date?
Oncodesign Precision Medicine S.A.’s upcoming earnings report date is Apr 08, 2026 which is in 234 days.
How were Oncodesign Precision Medicine S.A.’s earnings last quarter?
Oncodesign Precision Medicine S.A. released its earnings results on Jul 31, 2025. The company reported €0.542 earnings per share for the quarter, beating the consensus estimate of N/A by €0.542.
Is Oncodesign Precision Medicine S.A. overvalued?
According to Wall Street analysts Oncodesign Precision Medicine S.A.’s price is currently Overvalued.
Does Oncodesign Precision Medicine S.A. pay dividends?
Oncodesign Precision Medicine S.A. does not currently pay dividends.
What is Oncodesign Precision Medicine S.A.’s EPS estimate?
Oncodesign Precision Medicine S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncodesign Precision Medicine S.A. have?
Oncodesign Precision Medicine S.A. has 18,190,878 shares outstanding.
What happened to Oncodesign Precision Medicine S.A.’s price movement after its last earnings report?
Oncodesign Precision Medicine S.A. reported an EPS of €0.542 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of Oncodesign Precision Medicine S.A.?
Currently, no hedge funds are holding shares in FR:ALOPM
Technical Analysis
Quantum Genomics
―
Hybrigenics SA Class A
―
TME Pharma N.V.
―
Biophytis SA
―
Theranexus SA
―